Die spezifische Immuntherapie (Hyposensibilisierung) mit Allergenen1

[1]  A. Pradalier,et al.  Sublingual‐swallow immunotherapy (SLIT) with a standardized five‐grass‐pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis , 1999, Allergy.

[2]  D. Caillaud,et al.  Sublingual‐swallow immunotherapy (SLIT) in patients with asthma due to house‐dust mites: a double‐blind, placebo‐controlled study , 1999, Allergy.

[3]  J Bousquet,et al.  Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. , 1998, The Journal of allergy and clinical immunology.

[4]  H. Løwenstein,et al.  Immunotherapy with partially purified and standardized tree pollen extracts. IV. Results from long‐term (6‐year) follow‐up , 1997, Allergy.

[5]  W. Pichler,et al.  Specific immunotherapy with Dermatophagoides pteronyssinus and D. farinae results in decreased bronchial hyperreactivity , 1997, Allergy.

[6]  T. Hirsch,et al.  Double‐blind placebo‐controlled study of sublingual immunotherapy with house dust mite extract (D. pt.) in children , 1997, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[7]  M. Mancino,et al.  Immunotherapy with an alum‐adsorbed Parietaria‐pollen allergoid: a 2‐year, double‐blind, placebo‐controlled study , 1997, Allergy.

[8]  C. Martínez-Cócera,et al.  A double‐blind, placebo‐controlled study of immunotherapy with grass‐pollen extract Alutard SQ during a 3–year period with initial rush immunotherapy , 1996, Allergy.

[9]  L. Frølund,et al.  A double-blind, randomized study investigating the efficacy and specificity of immunotherapy with Artemisia vulgaris or Phleum pratense/betula verrucosa. , 1995, Allergologia et immunopathologia.

[10]  M. Cazzola,et al.  Immunotherapy with Alpare® in patients with respiratory allergy to Parietaria pollen: a two year double‐blind placebo‐controlled study , 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[11]  E. Pastorello,et al.  Clinical and immunological effects of immunotherapy with alum‐absorbed grass allergoid in grass‐pollen‐induced hay fever , 1992, Allergy.

[12]  A. Helbling,et al.  Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety. , 1992, The Journal of allergy and clinical immunology.

[13]  J. Bousquet,et al.  Differences in clinical and immunologic reactivity of patients allergic to grass pollens and to multiple-pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts. , 1991, The Journal of allergy and clinical immunology.

[14]  A. Helbling,et al.  Honeybee venom allergy: results of a sting challenge 1 year after stopping successful venom immunotherapy in 86 patients. , 1991, The Journal of allergy and clinical immunology.

[15]  S. Durham,et al.  Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. , 1991, BMJ.

[16]  J. Anderson,et al.  Risk of systemic reactions in patients taking beta-blocker drugs receiving allergen immunotherapy injections. , 1990, The Journal of allergy and clinical immunology.

[17]  J. Bousquet,et al.  Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract. , 1990, The Journal of allergy and clinical immunology.

[18]  J. Bousquet,et al.  Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. III. Efficacy and safety of unfractionated and high-molecular-weight preparations in rhinoconjunctivitis and asthma. , 1989, The Journal of allergy and clinical immunology.

[19]  R. Einarsson,et al.  Immunotherapy with dog and cat allergen preparations in dog-sensitive and cat-sensitive asthmatics. , 1989, Annals of allergy.

[20]  R. Patterson,et al.  The safety and activity of polymerized ragweed: a double-blind, placebo-controlled trial in 81 patients with ragweed rhinitis. , 1987, The Journal of allergy and clinical immunology.

[21]  H. Malling,et al.  Clustered Immunotherapy with Yellow Jacket Venom , 1985, Allergy.

[22]  D. Golden,et al.  Dose dependence of Hymenoptera venom immunotherapy. , 1981, The Journal of allergy and clinical immunology.

[23]  R. Jones,et al.  Rush venom immunotherapy program for honeybee sting sensitivity. , 1979, The Journal of allergy and clinical immunology.

[24]  G. Canonica,et al.  Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. , 1999, The Journal of allergy and clinical immunology.

[25]  H. Löllgen,et al.  Akuttherapie anaphylaktoider Reaktionen , 1994, Der Anaesthesist.

[26]  J. Bousquet,et al.  Immunotherapy with Hymenoptera venoms. Position paper of the european academy of allergy and clinical immunology , 1987 .